Redefining Early Stage Investments (RESI) 2021 | Life Science Nation, LLC | 16 November 2021 | Webinar Event

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Who Should Attend?
RESI is committed to facilitating conversations that spark early-stage deals in across drugs, devices, diagnostics, and digital health that save lives and change the world through healthcare innovation. To advance the most successful deals, all major players, including both buyers and sellers, are saved a seat at the table. RESI attracts incubators, tech transfer offices, universities, hospitals, research labs and their constituents getting on the radar of investors and channel partners. Biotech, medtech, diagnostics, and digital health companies source global investors and strategic partners, create relationships, and pitch to secure funding from Seed to Series B.

What to Expect?
• Panels
• Partnering
• Pitch Challenge
• Workshops

2021 Speakers

Travis Whitfill
Sr.Director – Global External Innovation, Ipsen

Cynthia Cai
Venture Partner, Viva BioInnovator

Ernst Geutjes
Partner, Aglaia Oncology Funds

Richard Ward
Director, Search and Evaluation, Oncology R&D BD, AstraZeneca

Thierry Wurch
Senior Director, Ipsen S.A.

Mylea Charvat
Partner & Principal, Digital Health Practice, LiquidSMARTS

Frances Taheri
Global Ventures Digital Health Lead, Accenture Ventures

Rohit Pratap Singh
Vice President, Investments, Xeraya Capital

Tiffany Yu
Vice President, Equality Asset Management LP

Andy Merken
Partner, Corporate and Securities Co-Chair, Life Sciences, Burns & Levinson

Jordan Milford
Director of Business Development and Strategy, Olympus Corporation

Rachel Rea
Director of Business Development and Licensing Medtronic

Christina Salys
Director of New Business Development, Intuitive Surgical

Keren Etkin
Author of “The Age Tech Revolution”, expected publication winter 2021 | Age-Tech Evangelist | Creator of TheGerontechnologist.com, TheGerontechnologist

Dave Dlesk
CEO, Embrace Prevention Care

Michael Fossel
President and Founder, Telocyte

Pepper Landson
CEO, Praetego Inc

Beth Sanders
Founder & CEO, LifeBio Inc

Dave Fogel
Member of Screening & Due Diligence Committees, Mass Medical Angels

Ruchi Dana
Board Member, Dana Group

Bryan Shao
K4 Deal Screening Committee, Keiretsu Forum

Thomas Vogelsong
Investor/Life Science Advisor/Director, Deal Flow, KYTO Technology and Life Science

Lu Zhang
Managing Partner, Fusion Fund

Xuhui Shao, PhD
Managing Partner, Foothills Ventures

Diana Saraceni
Founder, Managing Director, Panakes Partners

Beth Hoffman
President & CEO, Origami Therapeutics

Randy Pritchard
CEO, Pillar Biosciences

Bharat Srinivasa
Investment Team, Amplitude Ventures

Kimberly Ha
Founder & CEO, KKH Advisors

Les Funtleyder
Healthcare Portfolio Manager, E Squared Capital; Chief Investment Officer TechNik

Shruti Gandhi
Founder & Managing Partner, Array Ventures

Chihiro Hosoya
BD/VC Head, Rx+ Business Accelerator, Astellas Rx+ Business Accelerator

Betsabeh Madani
Life Science & Healthcare Investor and Advisor

Alex Morgan
Partner, Khosla Ventures

Tom Gibbs
Director, Debiopharm Innovation Fund

Nissim Darvish
Senior Managing Director (Israel), OrbiMed Advisors LLC

Baudouin Hue
Partner, Karista

Justin Leushner
Partner, Launchit Ventures

Patrik Sobocki
Investment Manager Life Science, Industrifonden

DJ (Dennis) Schmitt
Founder/CEO, Neuro20 Technologies

Sangeeta Agarawal
CEO and co-founder, Helpsy Health

Jonathan Cohen
CEO, 20/20 GeneSystems

Lana Feng
Co-Founder & CEO, HumaAI Inc

Rachel Braun Scherl
CEO, SPARK Solutions for Growth

Taja Lester
Managing Partner, Health Equity Capital

Petra Meyer
Managing Director – HealthCare Sector Group Lead, Golden Seeds

Brenda Irwin
Managing Partner & Co-Founder, Relentless Venture Fund

Brian Meshkin
Managing Partner, Profound Ventures

Yury Kukushkin
Investment Director, JDRF T1D Fund

Richard Lipkin
Co-Founder, Co-Chair, The Catalytic Impact Foundation

Andrew Meadow
General Partner, Health Innovation Capital

Sasha Naydich
Associate, Myeloma Investment Fund

André Harrell
Venture Partner, Cancer Fund

2021 Sponsors and Partners

TITLE SPONSORS:
• McDermott Will & Emery
• Big4Bio
• Life Science Nation

GOLD SPONSORS:
• Medmarc
• First Republic

SILVER SPONSORS:
• Burns Levinson
• Trinet

GLOBAL TECH HUB GATHERING:
• BIO Mansfield Incubator
• Intuitivex
• Georgia Bio
• Harvard Innovation Labs
• SAPA
• UCLA
• Medicon Valley Alliance
• Biondustry Park
• NLC
• Lyon Bio Pole
• Genopole
• BioRN
• Life Science Zurich
• Murrieta
• The Brink
• BusStim
• Massachusetts Life Sciences Center
• French American Chamber of Commerce
• Building Global Innovators
• Trinity Templar
• LifeX
• Crohn's & Colitis Foundation
• LSO
• Canada
• Azbio
• Vils
• Biote Canada
• North Carolina Biotechnology Center
• Ontario Bioscience
• Bio

MEDIA PARTNERS:
• Freemind
• Big4Bio
• BioPartner
• Israel Export Institute
• Life Sciences Queensland
• Murrieta
• Pitch-N-Ski
• LyonBioPole
• Gene Online
• GBI
• Isipr
• Biotech Gate